Royce & Associates LP cut its stake in SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report) by 0.9% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 858,806 shares of the company’s stock after selling 7,450 shares during the period. Royce & Associates LP’s holdings in SIGA Technologies were worth $5,797,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of SIGA. Vanguard Group Inc. raised its holdings in shares of SIGA Technologies by 1.9% in the 1st quarter. Vanguard Group Inc. now owns 2,283,612 shares of the company’s stock worth $19,548,000 after purchasing an additional 41,515 shares during the period. AltraVue Capital LLC raised its holdings in SIGA Technologies by 6.6% in the second quarter. AltraVue Capital LLC now owns 2,177,646 shares of the company’s stock valued at $16,528,000 after buying an additional 134,450 shares during the period. Tidal Investments LLC acquired a new position in SIGA Technologies during the first quarter valued at approximately $157,000. Harbor Capital Advisors Inc. purchased a new stake in SIGA Technologies during the third quarter worth approximately $1,098,000. Finally, Allspring Global Investments Holdings LLC increased its position in shares of SIGA Technologies by 172.1% in the third quarter. Allspring Global Investments Holdings LLC now owns 211,236 shares of the company’s stock worth $1,426,000 after acquiring an additional 133,597 shares in the last quarter. 55.40% of the stock is currently owned by hedge funds and other institutional investors.
SIGA Technologies Price Performance
NASDAQ:SIGA opened at $6.18 on Tuesday. The business’s 50-day moving average is $7.14 and its two-hundred day moving average is $7.95. The firm has a market capitalization of $441.25 million, a PE ratio of 5.15 and a beta of 0.89. SIGA Technologies, Inc. has a 12 month low of $4.26 and a 12 month high of $12.83.
SIGA Technologies Profile
SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.
Featured Stories
- Five stocks we like better than SIGA Technologies
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Comparing and Trading High PE Ratio Stocks
- Applied Materials Market Capitulates: Now is the Time to Buy
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding SIGA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SIGA Technologies, Inc. (NASDAQ:SIGA – Free Report).
Receive News & Ratings for SIGA Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SIGA Technologies and related companies with MarketBeat.com's FREE daily email newsletter.